Hemoglobin A1C
%
HbA1c serves as a metabolic report card, reflecting long-term glucose control and helping identify prediabetes and diabetes risk before serious complications develop.
Optimal Range
<5.7%
optimal 4.8-5.4%
EssentialAdvancedMax
Your metabolism determines how efficiently your body converts food into energy. This panel assesses blood glucose regulation, insulin sensitivity, and key metabolic markers to help you catch pre-diabetes early, optimise energy levels, and support a healthy weight.
HbA1c serves as a metabolic report card, reflecting long-term glucose control and helping identify prediabetes and diabetes risk before serious complications develop.
Optimal Range
<5.7%
optimal 4.8-5.4%
eAG provides an intuitive understanding of long-term glucose control by translating HbA1c into familiar blood glucose values for better patient comprehension.
Optimal Range
97-137 mg/dL (corresponding to HbA1c 4.8-5.4%)
optimal 97-118 mg/dL
eAG in mmol/L offers international standard glucose monitoring, translating HbA1c into metric units for global healthcare compatibility.
Optimal Range
5.4-7.6 mmol/L (corresponding to HbA1c 4.8-5.4%)
optimal 5.4-6.6 mmol/L
Fasting glucose serves as a cornerstone marker for glucose metabolism, with optimal levels indicating efficient insulin function and metabolic health.
Optimal Range
70-99 mg/dL
optimal 75-85 mg/dL
Energy & Metabolism
Energy & Metabolism
Energy & Metabolism
Energy & Metabolism
Energy & Metabolism
Fasting insulin serves as an early warning system for metabolic dysfunction and insulin resistance, often detecting problems years before glucose becomes abnormal.
Optimal Range
2-19 μIU/mL fasting
optimal 2-10 μIU/mL
LDL cholesterol requires context of particle size, density, and oxidation status for accurate cardiovascular risk assessment. Small, dense, oxidized LDL particles pose the greatest risk.
Optimal Range
<100 mg/dL
optimal <70 mg/dL for high-risk individuals
Energy & Metabolism
Energy & Metabolism
Energy & Metabolism
Energy & Metabolism
Blood Glucose
Optimal Range
1.1 - 2.1 ng/mL
Blood Glucose
Optimal Range
0 - 45 score
Blood Glucose
Metabolism is not a single process but a vast network of biochemical reactions that convert food into the energy currency of every cell. At its core, metabolic health describes how effectively cells take up glucose and fats, produce ATP, and regulate energy storage. When this machinery works optimally, you maintain stable energy, healthy body composition, sharp cognition, and resilience against chronic disease. When it breaks down — through insulin resistance, mitochondrial dysfunction, or dysregulated appetite hormones — the consequences are far-reaching.
Type 2 diabetes now affects over 500 million adults globally, yet the metabolic dysfunction driving it typically develops silently for 10–15 years before diagnosis. Fasting insulin, HOMA-IR, and HbA1c detect this progression years before a diabetes diagnosis, enabling intervention at a stage where diet and lifestyle changes are highly effective and potentially curative. Testing your metabolic markers is one of the highest-yield investments you can make in long-term health.
Metabolism health does not exist in isolation — it is deeply intertwined with every major system.
The pancreatic beta cells are the primary metabolic sensors, releasing insulin in response to rising blood glucose. In insulin resistance, beta cells compensate by secreting more insulin — a state that can persist for years before glucose finally rises. Measuring fasting insulin directly quantifies this compensatory hyperinsulinaemia. Amylase and lipase from exocrine pancreatic cells are measured alongside metabolic markers, since pancreatic exocrine insufficiency can impair nutrient absorption and worsen metabolic status.
The liver is the metabolic switchboard, producing glucose during fasting (gluconeogenesis and glycogenolysis) and clearing it after meals. Insulin resistance in the liver — hepatic insulin resistance — is often the earliest site of dysfunction, causing excess hepatic glucose output and driving fasting hyperglycaemia. Non-alcoholic fatty liver disease (NAFLD), present in 90% of people with type 2 diabetes, further impairs hepatic glucose and lipid metabolism. ALT elevation is frequently the first laboratory signal of worsening insulin resistance.
Visceral fat — the metabolically active fat surrounding the abdominal organs — is not merely an energy reserve but an endocrine organ. Excess visceral fat secretes pro-inflammatory adipokines (TNF-α, IL-6, resistin) that drive systemic insulin resistance and elevate hs-CRP. Adiponectin, which improves insulin sensitivity, is paradoxically reduced in obesity. The adipose-inflammation axis means that metabolic dysfunction and cardiovascular risk are deeply intertwined — both worsen together.
Thyroid hormones set the pace of all metabolic reactions by controlling mitochondrial uncoupling proteins and oxygen consumption. Hypothyroidism slows metabolic rate by 15–40%, causing weight gain, cold intolerance, and fatigue even at normal caloric intake. Conversely, hyperthyroidism accelerates metabolism, causing weight loss and heat intolerance despite increased appetite. Every person with unexplained weight changes or fatigue should have TSH measured alongside metabolic markers.
Clinical Note
Metabolic testing should be performed in a fasted state (10–12 hours, water only) for glucose, insulin, and lipid markers. HbA1c does not require fasting and reflects 2–3 months of average glucose, making it complementary to spot fasting values. Testing both fasting insulin and fasting glucose provides the most complete picture of insulin resistance at its earliest detectable stage.
Insulin resistance is a condition in which cells become less responsive to insulin, forcing the pancreas to produce more to keep blood sugar normal. It is detected by measuring fasting insulin alongside fasting glucose. The HOMA-IR score (fasting insulin × fasting glucose ÷ 405) quantifies resistance. A score above 2.0 indicates early resistance; above 3.0 is significant. HbA1c and fasting glucose alone often appear normal for years while insulin resistance progresses.
Fasting glucose measures blood sugar at a single moment after an overnight fast, reflecting immediate glucose control. HbA1c (glycated haemoglobin) measures the percentage of haemoglobin molecules that have glucose attached, reflecting average blood sugar over the past 2–3 months. Both are needed for a complete metabolic picture — fasting glucose is more sensitive to acute changes while HbA1c reveals chronic patterns. Normal fasting glucose is below 100 mg/dL; optimal HbA1c is below 5.4%.
Yes. "Metabolically obese normal weight" (MONW) or "thin on the outside, fat on the inside" (TOFI) describes people with normal BMI but elevated visceral fat, insulin resistance, and dyslipidaemia. Studies suggest 20–30% of normal-weight adults have at least one metabolic abnormality. Blood testing — not body weight — is the definitive way to assess metabolic health.
The most evidence-backed interventions are: (1) reducing refined carbohydrate and sugar intake, which directly lowers fasting glucose and insulin; (2) resistance training, which increases glucose uptake by muscle cells independently of insulin; (3) moderate aerobic exercise, which improves insulin sensitivity within days; (4) sufficient sleep — even one night of sleep deprivation raises fasting glucose by 15–23%; and (5) time-restricted eating, which reduces daily insulin exposure and improves HbA1c over 3–6 months.
Uric acid is a byproduct of purine metabolism. Elevated levels (hyperuricemia) are associated with gout, kidney stones, and increasingly with insulin resistance, hypertension, and non-alcoholic fatty liver disease. High fructose consumption is the primary driver of elevated uric acid in modern diets. An optimal uric acid level is below 5.5 mg/dL for men and below 4.5 mg/dL for women.
Join thousands who have discovered their health optimization opportunities through comprehensive metabolism testing.